Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.
about
Studies on the antihypertensive and antidyslipidemic activities of Viola odorata leaves extractPhotoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligandRole of the extracellular signal-regulated kinase (Erk) signal transduction cascade in alpha(2) adrenoceptor-mediated vasoconstriction in porcine palmar lateral veinVasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinaseStudies on the mechanism of action of various vasodilatorsAntihypertensive and renal effects of nicardipineBlood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranololStudies on the bradycardia induced by bepridilFrom a traditional medicinal plant to a rational drug: understanding the clinically proven wound healing efficacy of birch bark extractBlocking and isolation of a calcium channel from neurons in mammals and cephalopods utilizing a toxin fraction (FTX) from funnel-web spider poison.Ca2+ channel blockers distinguish between G protein-coupled pharmacomechanical Ca2+ release and Ca2+ sensitization.Antispasmodic and vasodilator activities of Morinda citrifolia root extract are mediated through blockade of voltage dependent calcium channels.Purification and affinity labeling of dihydropyridine receptor from rabbit skeletal muscle membranes.Vascular Remodelling Relates to an Elevated Oscillatory Shear Index and Relative Residence Time in Spontaneously Hypertensive RatsNifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trialAntiurolithic activity of Origanum vulgare is mediated through multiple pathwaysMedical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol.Diltiazem treatment for the management of ischaemia in patients with poor left ventricular function: safety of long term administration.Pharmacological basis for the medicinal use of Holarrhena antidysenterica in gut motility disorders.Biochemical mechanisms of drug action: what does it take for success?Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.Calcium channel antagonists: pharmacological considerations.Calcium antagonists and their mode of action: an historical overview.Blood pressure, heart rate and A-V conduction responses to nicardipine in hypertensive patients receiving atenolol.Anti-hypertensive dose-response effects of nicardipine in stable essential hypertensionCardiovascular pharmacology of nicardipine in animalsNicardipine for stable angina pectorisShort-term effects of felodipine, a new dihydropyridine, in hypertension.Direct and indirect effects of calcium entry blocking agents on isovolumic left ventricular relaxation in conscious dogsPharmacological Evaluation of Prosopis cineraria (L.) Druce in Gastrointestinal, Respiratory, and Vascular Disorders.Antispasmodic and Antidiarrheal Activities of Valeriana hardwickii Wall. Rhizome Are Putatively Mediated through Calcium Channel BlockadeStudies on tracheorelaxant and anti-inflammatory activities of rhizomes of Polygonatum verticillatum.Antispasmodic and antidiarrhoeal activity of the fruit of Rosa moschata (J).In-vitro and in-vivo validation of ethnopharmacological uses of methanol extract of Isodon rugosus Wall. ex Benth. (Lamiaceae)The effects of diltiazem (CRD-401) on the membrane and mechanical properties of vascular smooth muscles of the rabbit.Scientific basis for use of Pyrus pashia Buch.-Ham. ex D. Don. fruit in gastrointestinal, respiratory and cardiovascular ailmentsalpha-adrenergic antagonists as possible calcium channel inhibitors.Pharmacological justification of use of Solena heterophylla Lour. in gastrointestinal, respiratory and vascular disorders.Nerve growth factor modulates the drug sensitivity of neurotransmitter release from PC-12 cells.
P2860
Q21245692-19BD286E-1B3F-47CA-BD9A-255B40016561Q28338137-DE069AF6-769B-4565-952D-A9AAA887A907Q28343918-70549057-46C1-4B88-A016-0574D7A86119Q28354356-E05E817A-FA8E-47DB-ABE0-DAC21B1F80E8Q28365828-3DD79F7A-4F26-4535-A59E-090A0ABB54DAQ28367097-B6B1A4CE-A9D9-4933-83F2-B3813BB27187Q28367306-AF9FF6B6-3C33-4316-A9D7-A5EB1AB48635Q28367689-96E4609E-1C66-4C5D-A797-F89D4DA84CC0Q28539007-3DA0EC44-5D88-434F-B43E-78A0F9974433Q29029753-06F00DBC-163A-4F67-BF7E-80BDA67858EBQ30447331-43E73E1D-9D1D-4800-8F92-94303194995FQ33523615-83E01AFD-3FEC-40F3-B8DD-2DE838B6C60CQ33569630-6AFA74D9-7E79-4727-9471-A7AD16B9F525Q33700578-F1690D92-CEB8-4CA0-8BED-ABC7671DE46CQ33999485-D375620C-4524-49B4-A2B5-27670033272AQ34049630-C570319F-FDD4-4D0F-8A6B-933AA4CFC29AQ34118252-3D818DFC-9DE7-41A9-8C39-24605ECDFCF9Q34118697-8D594496-5760-4A32-87C5-9809C4ED4C67Q34118770-7267B802-AB9E-46D9-92E8-80472E1FB5B6Q34136496-77943586-98D8-430E-A58B-34EC9CDEE1F4Q34344862-2C6A3373-B3F0-4E15-A1BB-06E51B82B541Q34397144-226FF66D-1478-4582-AE79-80E889216519Q34446580-77859427-EA66-4004-84C9-F597D48AAE21Q34446780-5DBFD2F3-EBBA-4CDF-AE30-622568304D5AQ34446878-56EBD228-112E-4BBA-8B1E-BC1273A18047Q34446893-0F6F1C20-BAEF-4383-97C5-A1C6486ED9E9Q34446900-DD80E759-5CDB-40D6-AB5B-595F3AE52877Q34446965-F87691C5-32E5-4A3F-98DC-4EEFE6AA1AA0Q34621102-C065FD75-E294-408F-AAC1-C7AE4E25064BQ34626613-E8C72B52-FB44-4D55-BB6F-87F1C0F3E9C5Q34648712-0E5F8224-6EBC-40EE-998E-6938380470E0Q34674163-0071C3B6-F458-411D-9827-5FEC3F9ED68AQ34878474-36529E8B-5F26-43A7-B968-B8B24DABAB22Q34996120-76ACFBE0-ECBC-445A-9FC7-35D6E4F94C94Q35100033-62F90EEC-FDBF-48FA-ADF7-2CD05172D0FFQ35177863-5691E076-DB95-463D-9598-9095D8069885Q35192605-9EE81FBF-DDE4-499D-8ECB-07CE9F732301Q35427514-37E0B565-3E82-41DE-86ED-DFE3454D3747Q35579104-E61090F4-DBE9-4768-8E29-04E826172B45Q35598146-16AD1AE7-F8EF-4215-BBCB-F90B62CF5890
P2860
Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Specific pharmacology of calci ...... s, and vascular smooth muscle.
@en
Specific pharmacology of calci ...... s, and vascular smooth muscle.
@nl
type
label
Specific pharmacology of calci ...... s, and vascular smooth muscle.
@en
Specific pharmacology of calci ...... s, and vascular smooth muscle.
@nl
prefLabel
Specific pharmacology of calci ...... s, and vascular smooth muscle.
@en
Specific pharmacology of calci ...... s, and vascular smooth muscle.
@nl
P1476
Specific pharmacology of calci ...... s, and vascular smooth muscle.
@en
P2093
Fleckenstein A
P304
P356
10.1146/ANNUREV.PA.17.040177.001053
P577
1977-01-01T00:00:00Z